131P Safety and clinical efficacy of roginolisib (IOA-244): The first oral allosteric modulator of phosphoinositide 3-kinase inhibitor delta (PI3Kδ)
| Autor: | Di Giacomo, A.M., Simonelli, M., Santangelo, F., Amato, G., Simonetti, E., Graham, J., Lahn, M., Di Conza, G., Hammett, T., Zorrilla, R., Kaur, P., Ziyang, T., Lakshmikanth, T., Brodin, P., Occhipinti, M., Carlo-Stella, C., Santoro, A., Spiliopoulou, P., Evans, T.R.J., Maio, M. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2023 20 Supplement |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|